Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2026-01-22 @ 10:40 AM
Study NCT ID:
NCT02725268
Status:
COMPLETED
Last Update Posted:
2021-11-24
First Post:
2016-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-30
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-28
First Submit QC Date:
None
Study First Post Date:
2016-03-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-05-22
Results First Submit QC Date:
None
Results First Post Date:
2020-06-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-28
Last Update Post Date:
2021-11-24
Last Update Post Date Type:
ACTUAL